18.26
price up icon4.16%   0.73
 
loading

Pharvaris Nv Stock (PHVS) Latest News

pulisher
Feb 03, 2025

JMP Securities Boosts Pharvaris (NASDAQ:PHVS) Price Target to $55.00 - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Pharvaris (NASDAQ:PHVS) Price Target Raised to $55.00 - Defense World

Feb 03, 2025
pulisher
Feb 01, 2025

Pharvaris (NASDAQ:PHVS) Shares Gap DownHere's Why - MarketBeat

Feb 01, 2025
pulisher
Jan 27, 2025

Where are the Opportunities in (PHVS) - Stock Traders Daily

Jan 27, 2025
pulisher
Jan 24, 2025

Barclays PLC Purchases New Holdings in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

FY2026 EPS Estimates for Pharvaris Decreased by Analyst - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

Why Is Andreas Halvorsen Bullish On Pharvaris N.V. (PHVS) Now? - Insider Monkey

Jan 23, 2025
pulisher
Jan 22, 2025

Leerink Partnrs Brokers Cut Earnings Estimates for Pharvaris - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

Pharvaris (NASDAQ:PHVS) Trading Up 5.3%What's Next? - MarketBeat

Jan 21, 2025
pulisher
Jan 17, 2025

How To Trade (PHVS) - Stock Traders Daily

Jan 17, 2025
pulisher
Jan 13, 2025

Pharvaris (NASDAQ:PHVS) Stock Price Down 11.7%Here's Why - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Pharvaris Advances Phase 3 HAE Programs, Expands Pipeline Into Acquired Angioedema Treatment - StockTitan

Jan 13, 2025
pulisher
Jan 12, 2025

Geode Capital Management LLC Boosts Holdings in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 12, 2025
pulisher
Jan 09, 2025

Barclays PLC Takes Position in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 09, 2025
pulisher
Jan 06, 2025

(PHVS) Long Term Investment Analysis - Stock Traders Daily

Jan 06, 2025
pulisher
Jan 06, 2025

Jane Street Group LLC Makes New Investment in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 06, 2025
pulisher
Jan 06, 2025

Jane Street Group LLC Acquires Shares of 28,418 Pharvaris (NASDAQ:PHVS) - MarketBeat

Jan 06, 2025
pulisher
Jan 03, 2025

Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

State Street Corp Purchases New Shares in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 03, 2025
pulisher
Jan 03, 2025

53,980 Shares in Pharvaris (NASDAQ:PHVS) Bought by State Street Corp - MarketBeat

Jan 03, 2025
pulisher
Dec 31, 2024

Pharvaris (NASDAQ:PHVS) Trading Down 3.5%Here's Why - MarketBeat

Dec 31, 2024
pulisher
Dec 29, 2024

Pharvaris: Despite 30% Decline, Still Fair At Best (NASDAQ:PHVS) - Seeking Alpha

Dec 29, 2024
pulisher
Dec 28, 2024

Pharvaris (NASDAQ:PHVS) Sees Large Decrease in Short Interest - MarketBeat

Dec 28, 2024
pulisher
Dec 27, 2024

Trend Tracker for (PHVS) - Stock Traders Daily

Dec 27, 2024
pulisher
Dec 20, 2024

Pharvaris (PHVS) Shares Cross Above 200 DMA - Nasdaq

Dec 20, 2024
pulisher
Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $906,000 in Pharvaris (NASDAQ:PHVS) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $906,000 Investment in Pharvaris (NASDAQ:PHVS) - MarketBeat

Dec 20, 2024
pulisher
Dec 16, 2024

Learn to Evaluate (PHVS) using the Charts - Stock Traders Daily

Dec 16, 2024
pulisher
Dec 14, 2024

Pharvaris (PHVS) Price Target Increased by 38.65% to 32.93 - MSN

Dec 14, 2024
pulisher
Dec 06, 2024

Pharvaris price target lowered to $46 from $50 at JMP Securities - Yahoo Finance

Dec 06, 2024
pulisher
Dec 05, 2024

Long Term Trading Analysis for (PHVS) - Stock Traders Daily

Dec 05, 2024
pulisher
Nov 25, 2024

Pharvaris Reports Q3 2024 Progress and Financials - TipRanks

Nov 25, 2024
pulisher
Nov 13, 2024

Pharvaris Reports 93% HAE Attack Reduction in Trial Data, Plans Phase 3 Study | PHVS Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Pharvaris to Present HAE Treatment Progress at Guggenheim Healthcare Conference | PHVS Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

PHVS Makes Notable Cross Below Critical Moving Average - Nasdaq

Nov 11, 2024
pulisher
Oct 30, 2024

Axonis Therapeutics Announces $115 Million Series A Financing - Financial Times

Oct 30, 2024
pulisher
Oct 24, 2024

Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

(PHVS) Proactive Strategies - Stock Traders Daily

Oct 23, 2024
pulisher
Oct 16, 2024

PHVSPharvaris N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at ... - The Hastings Tribune

Oct 16, 2024
pulisher
Oct 16, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings - StockTitan

Oct 16, 2024
pulisher
Oct 15, 2024

Pharvaris to Host Virtual Investor Event on October 23, 2024 - StockTitan

Oct 15, 2024
pulisher
Oct 13, 2024

(PHVS) Investment Report - Stock Traders Daily

Oct 13, 2024
pulisher
Oct 09, 2024

Pharvaris (NASDAQ:PHVS) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Oct 09, 2024
pulisher
Oct 03, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at - The Bakersfield Californian

Oct 03, 2024
pulisher
Oct 03, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop - StockTitan

Oct 03, 2024
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):